Susquehanna International Group, LLP Cor Medix Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Cor Medix Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 189,851 shares of CRMD stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
189,851
Previous 322,350
41.1%
Holding current value
$2.18 Million
Previous $1.99 Million
17.78%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding CRMD
# of Institutions
183Shares Held
32.6MCall Options Held
881KPut Options Held
583K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.9 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$29.7 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.4 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $474M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...